Medicine
Rebif kit
Rebif kit is a prescription medicine containing Interferon beta-1a for subcutaneous use, marketed by EMD Serono, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
REBIF should be stored refrigerated between 36°F to 46°F (2°C to 8°C). DO NOT…
Key facts
- Active ingredient (INN)
- Interferon beta-1a
- Brand
- Rebif
- Dosage form
- Kit
- Route
- Subcutaneous
- Packs
- 1 kit
- Marketing authorisation holder
- EMD Serono
- Manufacturer
- EMD Serono
- Origin register
- US FDA, United States
- Storage
- REBIF should be stored refrigerated between 36°F to 46°F (2°C to 8°C). DO NOT FREEZE. If needed, REBIF may be stored between 36°F to 77°F (2°C to 25°C) for up to 30 days and away from heat and light, but refrigeration is preferred.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L03AB07 Interferon beta-1a
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 17 December 2004
- Identifiers
- RxCUI 758025, 758027, 758028 +7DailyMed set ID c6fcb5d2-8fcd-44fa-a838-b84ee5f44f0fNDC 44087-8822Application BLA103780
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 kit in 1 carton * .2 mL in 1 syringe, glass * .5 mL in 1 syringe, glass | 44087-8822-1 | EMD Serono | 17 December 2004 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Interferon beta-1a kit.
Other strengths and forms of Interferon beta-1a
Clinical summary
Interferon beta-1a is an interferon beta indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. MedsAcross supplies Interferon beta-1a for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Interferon beta-1aFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Avonex prescribing information (Biogen) · U.S. National Library of Medicine, DailyMed
- Avonex: European public assessment report (EPAR) · European Medicines Agency
- Rebif: European public assessment report (EPAR) · European Medicines Agency
Need Rebif kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.